top of page

2023

更新日:2023年9月29日

  1. K Matsumoto, T Kuwata, W Tolbert, J Richard, S Ding, J Prévost, S Takahama, G Judicate, T Ueno, H Nakata, T Kobayakawa, K Tsuji, H Tamamura, A Smith, M Pazgier, A Finzi, S Matsushita. Characterization of a novel CD4 mimetic compound YIR-821 against HIV-1 clinical isolates. J Virol 97, e01638-22, 2023

  2. D Kamori, G Barabona, J Rugemalila, W Maokola, S Masoud, M Mizinduko, A Sabasaba, G Ruhago, V Sambu, J Mushi, G Mgomella, J McOllogi, F Msafiri, S Mugusi, J Boniface, R Mutagonda, L Mlunde, D Amani, E Mboya, M Mahiti, A Rwebembera, T Ueno, A Pembe, P Njau, B Mutayoba, B Sunguya. Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on antiretroviral therapy in Tanzania: Findings from a national representative HIV drug resistance survey. J Antimicrob Chemother. 2023: dkad010. doi: 10.1093/jac/dkad010

  3. Mako Toyoda, Toong Seng Tan, Chihiro Motozono, Godfrey Barabona, Akiko Yonekawa, Nobuyuki Shimono, Rumi Minami, Yoji Nagasaki, Yusuke Miyashita, Hiroyuki Oshiumi, Kimitoshi Nakamura, Shuzo Matsushita , Takeo Kuwata, Takamasa Ueno.Evaluation of Neutralizing Activity against Omicron Subvariants in BA.5 Breakthrough Infection and Three-Dose Vaccination Using a Novel Chemiluminescence-Based, Virus-Mediated Cytopathic Assay.https://doi.org/10.1128/spectrum.00660-23

  4. Emmanuel Nkuwi, George P. Judicate, Toong Seng Tan, Godfrey Barabona, Mako Toyoda, Bruno Sunguya, Doreen Kamori, Takamasa Ueno.Relative resistance of patient-derived envelope sequences to SERINC5-mediated restriction of HIV-1 infectivity Journal of Virology DOI: 10.1128/jvi.00823-23


コメント


Ueno Lab.

bottom of page